Accelerated Cervical Cancer Control: Cancer Moonshot
There are several challenges to cervical cancer control worldwide. Areas with ample resources available still face the issues of inefficient screening, overtreatment, and low HPV vaccine uptake rates. In contrast, areas with limited resources struggle with unsustainable multi-visit screening programs, limited treatment options, and reduced accessibility to HPV vaccines.
To overcome these barriers, NCI researchers are creating new cervical cancer screening approaches that are effective and efficient. For high resource settings, the investigators are designing a quick and cost-effective HPV genotyping assay to improve the detection and management of cervical cancer.
Additionally, NCI researchers are developing an artificial intelligence approach, called automated visual evaluation, that can analyze digital images of a woman’s cervix and accurately identify cervical precancers. This method could improve the reach and effectiveness of cervical cancer screening in low resource settings, since it only requires minimal training with the use of a cell phone or camera.